-
Our picks
-
Should every newborn be tested genetically?
Francesco Cardona posted a topic in ethical and legal aspects,
Should every newborn be tested genetically? (!)-
- 3 replies
-
-
Ultrasound guided vascular access and deep access PVC.
Pontus Johansson posted a topic in practical procedures,
Ultrasound guided vascular access and deep access PVC - what is your practices?-
- 4 replies
-
-
EBNEO COMMENTARY: SURFACTANT ADMINISTRATION VIA LARYNGEAL MASK AIRWAY VERSUS BRIEF TRACHEAL INTUBATION IN PRETERM INFANTS.
EBNEO posted a topic in EBNEO Reviews,
New EBNEO commentary, about surfactant through LMA (Laryngeal Mask Airway).
Check out and join the discussion!-
- 0 replies
-
-
Plenty of workshops, meetings and conferences coming up! Like N3, FICare, and many more!
Stefan Johansson posted an article in 99nicu News,
Plenty of workshops, meetings and conferences coming up, like N3, FICare, and many more!-
- 0 replies
-
-
Potassium disorder / pseudohyperkalemia
Greice Batista posted a topic in fluid and electrolyte balance,
Potassium disorder / pseudohyperkalemia - how to define and how to manage?-
- 4 replies
-
-
Antibiotic stewardship in the NICU - what do you do in clinical practise?
Stefan Johansson posted a topic in infections,
Antibiotic stewardship in the NICU - how do you do this in clinical practise?-
- 3 replies
-
-
-
Latest Topics
-
- 3 replies
- 871 views
-
- 4 replies
- 716 views
-
- 0 replies
- 238 views
-
- 4 replies
- 998 views
-
Neo Pod T Transport Humidifier out of stock
By Katja, in Ventilators and Care of the Ventilated Infant
- 5 replies
- 1,917 views
-
EBNEO COMMENTARY: SURFACTANT ADMINISTRATION VIA LARYNGEAL MASK AIRWAY VERSUS BRIEF TRACHEAL INTUBATION IN PRETERM INFANTS.
By EBNEO, in EBNEO Reviews
- ebneo
- surfactant
- (and 3 more)
- 0 replies
- 1,267 views
-
EBNEO COMMENTARY: NUTRITIONAL SUPPORT FOR MODERATE-TO-LATE-PRETERM INFANTS
By EBNEO, in EBNEO Reviews
- 0 replies
- 599 views
-
EBNEO COMMENTARY: THE IMPACT OF TIMING OF INGUINAL HERNIA REPAIR ON OUTCOMES IN PRETERM INFANTS
By EBNEO, in EBNEO Reviews
- 1 reply
- 983 views
-
- 2 replies
- 810 views
-
- 2 replies
- 920 views
-
-
Latest News
-
- 0 comments
- 116 views
- Added by Stefan Johansson
-
- 4 comments
- 1,903 views
- Comment by Efe
-
-
Latest Blog Entries
-
Hi
there seem to be enough evidence about the lack of beneficial effect of treatment of the PDA!
The approach to a hemodinámica significant ductus has changed significantly in the last 10 years.
Years ago we weee so obsessed that indocin prophylaxis was standard in many NICUs and early treatment became standard across the board.
I remember going to Dr Clayman PDA lecture at PAS where the PDA was seen as a demon
many babies had been exposed to surgical ligation with a known consecuentes of a surgery on a small premie baby
since William Benitez published his meta analysis about PDA there has been a definitive change in some centers on how to approach it and some has gone away from early treatment and surgery
there are other centers that continue to ignore the Trent and treat the PDA like we used to 10 years ago.
we I have noted in my practice is that regardless of the PDA size; baby that are on Mechanical ventilation after 7-10 days we give a course of tapering Decadeon (DATRT) and they get extubated
i Belice fluid/sedation/lung protective strategy and steroids when use appropriately will result in better outcomes for our micro premie of 22-26 weeks
whats are you doing in your practice?
thanks
-
Had a chance to attend #TEIBIO -
Transference (of knowledge Entrepreneurship ) & Innovation in Biotech .
inspirational talk on rare diseases awareness day and topics were bringing hope to paediatrics #nicu: by address solutions to Neonatal Congenital Heart #CHD ❤️and better tolerance heart transplant.
- 💡Crazy scienceco-founder Dr. Beatriz Salvador shows us how her team have found a non-invasive treatment for Congenital Diaphragmatic Hernia.
They were able the hole in CDH by regulating the immune system.
Have had 75%success rate and animal models have shown low toxicity.
Currently recognized as an orphan drug EU - finalize animal model trial in a non-rodent model.
Hopes to begin clinical trials in 2025 with the esteem collaboration of Dra. Mayte Vallejo, del Instituto para la Investigación Biomédica del Hospital Universitario La Paz de Madrid (IDIPAZ) y paciente advocacy association «La vida con Hernia Diafragmática Congénita» located in Mérida, Spain.
Crazy Science & Business S.L.
https://crazyscience.es
Rafael C. Rocha THYTECH founded a start-up to find a solution to avoid rejection in❤️ transplant in babies. Here the team are using an infant's timus cell to avoid rejection.
https://es.linkedin.com/company/thytech
Thanks to Carlos Cosculluela Chocarro for the shout-out. @FundacionDRO AsBioMad
-
The 99nicu.org web site is built on the Invision Power Board software.
In the next version (v5) there will be a major overhaul of the user interface, allowing for an even better way of presenting and browsing content here.
You can get a sneak preview in the video below (a bit techy, but still )
-
I don’t need to expand on how Internet and social media have shifted the paradigm for professional discussion. You know this!
Painful it is, but I wanted to share that I have decided to close my Twitter/X account. I will miss you tweeps. But... see you soon elsewhere!
I started to build a network on Twitter in 2009, exploring this new channel for communication about research and medicine. Twitter was different then, compared to what X has become. In the earlier years, Twitter impersonated open, high-level and cross-professional discussions. Despite different opinions shared, the feed was a friendly gathering. If you posted something seemingly controversial (or something not at all controversial about Covid-19, liberal democracy values, suffering among immigrants, or aggressive warfare), people commented in a respectful manner. You did not get a load of automated bot replies (from "verified accounts" with like ~10 followers) telling you were a moron and should XYZ!
Importantly, #NeoTwitter, #NeoEBM and #foamneo all grew into valuable resources. I am so grateful for connecting with you and other wonderful people there. It has indeed enriched my professional life, and often made me think twice.
With X and the new leadership by Musk et al (btw, is there even an “al”?), I have simply taken the consequence of not compromising with my values. That’s why I will delete my X account soon, after saying good bye to comrades there. The principal reason is that I don’t want to contribute to a communication platform where hate speech, conspiracy theories, and fake news is given this much space. The world of today is complicated enough as it is.
Although my own feed is still pretty OK, I feel that sharing a communication platform with the “dark side” (and don’t underestimate the force of it), implies that my presence there, as a person and as a professional, legitimate the bad stuff. In fact, this might even be an intentional business strategy of the X management team.
There is certainly some “alternative cost” to rebuild a neonatal network on a new platform. But I am fine with that. For myself, this is a step worth taking to get rid off the feeling that I am also, to some symbolic extent, feeding the trolls on X.
For the time being, I will stick to LinkedIn, while hoping to rebuild a network feed on our NICUVERSE Mastodon-server and/or on Bluesky. So, might see you there
And of course, maybe the future holds a renaissance for 99nicu.org with its older-school web site-based discussions.
Please note that this is a personal decision and about my own Tw/X account. However, within the 99nicu Team, we are also discussing an X-it strategy, but we need to make sure we have the organization's best interest in mind. And, with our upcoming conference, we may choose to keep the 99nicu account up and running to for sharing the word about our conference plans. After all, #NeoTwitter is still a great place for reaching out.
Thanks to the Verge for making the graphics illustrating this post
-
-
Upcoming Events
-
11 September 2024 07:00 AM Until 13 September 2024 04:00 PM
0The upcoming ECPM 2024 is organized by esteemed European Association of Perinatal Medicine (EAPM). This congress will provide physicians, researchers, trainees and students an excellent opportunity to discuss and explore a wide range of crucial topics in perinatal medicine.
Stay tuned for more updates on the programme and registration at ecpmcongress.eu
-
12 September 2024
0Certification in Neonatal Therapy 2021
Requirements for Certification in Neonatal Therapy include Qualified and Licensed Therapist who is holding Elite membership of Association of Neonatal Therapists. He/she should have completed 40 hours of training in neonatal therapy/care (direct teaching and or webinar), upto 350 hours of Direct Mentoring in Affiliated Set up. Kindly use following checklist for your reference.
1) Completed Post Graduation (Final year student can apply)
2) Active License
3) Elite Member of Association of Neonatal Therapists
4) Active professional membership of ANT
5) 40 hours of training in neonatal therapy (direct teaching / online webinar) ...scrutiny about validity of the courses will be done.
6 ) 350 + hours of Direct mentoring in affiliated set up - after examination
Cost Rs. 40000/- (Approximately)
7) Exam fees INR 1000/- Rs
😎 TRAIN Workshop completion (during mentorship)
-
19 September 2024 06:00 AM Until 20 September 2024 12:30 PM
0The purpose of this workshop is to increase the skills on the use of NAVA ventilation and lung ultrasound (LUS) in the NICUs. This is the first time we combine both modalities to offer the participants two new ways to enlarge their treatment and diagnosis options. Some previous experience and theoretical knowledge of NAVA and LUS as well as suitable equipment is of advantage (Servo-i or Servo-n ventilators, US machine with a LUS compatible probe).
The workshop will focus on
- interpretation of the Edi signal - interpretation of LUS findings
- utilization of the monitoring capabilities - making a diagnosis using LUS
- individualization of the treatment - implementation of LUS in the NICU
- implementation of NAVA in the NICU
We aim to get together a group of NAVA and LUS users at the same level of experience. We encourage you to participate as a team of both doctor and nurse participants.
The course includes both theory sessions and bedside teaching with the patients on NAVA ventilation in the NICU. LUS examinations will also be performed with NICU patients. Each participant is invited to present a patient case which has a teaching point on either NAVA or LUS.
TIME AND PLACE
The course will be held in September 19-20, 2024 in Turku, Finland by Dr Hanna Soukka, Professor Liisa Lehtonen, Dr Frank Fuchs and Dr Nadya Yousef at the Turku University Hospital.
REGISTRATION AND ACCOMODATION
You can apply for the course by contacting Hanna Soukka at hanna.soukka@utu.fi. The registration fee is 800 € + taxes including the lunches and refreshments during the workshop. The participants are responsible to arrange their travelling and accommodation by themselves at their own expense. For more information, contact Dr Hanna Soukka, hanna.soukka@utu.fi
Turku University Hospital
Majakkasairaala, Savitehtaankatu 5
Lecture hall Bengtskär, 3rd floor
Turku NAVA 2024.pdf
-
25 September 2024 06:00 AM Until 27 September 2024 11:00 AM
0Objectives
This seminar will provide an understanding of the pharmacological principles known as evidence-based pharmacology that will translate into daily clinical practice and provide participants (neonatologists, pediatricians, pharmacists, nurses, pharmacologists, pharmacometricians, and many others) interested in the field with the latest updates. As a novelty, participants will also be invited to present and discuss interesting pharmacological cases with the faculty and each other.
-
02 October 2024 Until 03 October 2024
0Please join us at FICare 2024, the 7th International Family Integrated Care Conference, Glasgow, UK & Virtual, October 2-3rd, 2024.
FICare 2024 brings together international neonatal families, researchers and clinical teams to share the latest research, innovations and practical approaches to put families at the heart of neonatal care.
Key themes for FICare 2024 include:
Personalising FICare – does one size fit all? Communication with families – what works, what doesn’t Music and signing in the NICU Parent-led co-design and innovation in FICare Implementing FICare: regional and national approaches Making FICare a strategic priority: Parent & Political Advocacy Sustaining FICare: getting past the 3C’s Culture, Covid & Capacity
For more details including our international expert faculty please visit:
https://cfsevents.eventsair.com/7th-international-family-integrated-care-conference-2024/
Abstract submission is now open until 31st July 2024:
https://cfsevents.eventsair.com/7th-international-family-integrated-care-conference-2024/abstracts
Early bird registration available until Tuesday 3rd September 2024.
For more information and any questions, please contact:
terrie@cfsevents.co.uk
-
02 October 2024
0N3 (Neonatal Nutrition Network - https://neonatalnutritionnetwork.org/) is arranging the next annual meeting on 2 October 2024!
Join a very exciting programme covering many different areas on neonatal nutrition and growth.
The day includes several interesting lectures and afternoon workshops. In response to previous feedback the workshops will run twice in the afternoon so as to maximise the chances for attendance for our delegates.
The meeting will be held in a hybrid format and all relevant information with details on registration can be found on the attached flyer. There is still time for the early bird fees
N3 24 autumn flyer programme.pdf
-
03 October 2024 Until 05 October 2024
0Objectives
IPOKRaTES seminars provide high quality postgraduate education which enables professionals to keep abreast of the most recent developments and offer participants the opportunity to discuss clinical problems or scientific issues personally with international experts.
This program will focus on:
1. Discuss current controversies related to nutrition of the neonate such as donor milk use, parenteral nutrition strategies, enteral nutrition composition and advancement, microbial therapeutics and optimization of breast feeding.
2. Appraise recent research related to optimization of nutrition for preterm infants.
3. Discuss implementation strategies for scientifically based nutritional guidelines.
4. Summarize recent advances in technology for evaluation of intestinal function.
5. Generate novel research roadmaps for early recognition and prevention of adverse outcomes such as “Necrotizing Enterocolitis”, “Bronchopulmonary Dysplasia,”, Retinopathy of Prematurity, Late Onset Sepsis and Growth Failure in preterm infants using artificial intelligence/machine learning and multiomic integration.
-
-
Links
-
Latest Pharmacopedia Posts
-
Gallery Feed